Skip to content
value.today
Amyris Inc. logo

Amyris Inc.

3A01.FUnlisted company
$332 Mlast known market cap, Jul 2023 — no current value
Compare
World rank
—
no current market cap
Revenue
$270 M
For year ending December-2022
Net income
$-529 M
-195.9% margin
SEC filing
Employees
980
As on 2021
value.today research

Amyris Inc. in brief

Amyris Inc. is an unlisted company in the Chemicals industry, based in Emeryville, California, USA. It was founded in 2003. In the year to December 2022 it had sales of $270 M and a net loss of $529 M. It employs about 980 people.

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

About Amyris Inc.

Amyris, Inc. manufactures ingredients made with synthetic biology and focused on the plant sugars into rare bioidentical molecules, essential ingredients and clean, effective everyday products. The headquarters is in USA.

Amyris company annual revenue is 269 million USD and annual net loss was -528 million USD for year ending December 2022.

Amyris Inc. timeline

5 events, 2003–2021
  1. 2003
  2. 🏁
    · approximate
    Founded
  3. 2006
  4. •
    · approximate
    First filing with the US SEC
    The company's first electronic filing in SEC EDGAR.
  5. 2010
  6. ✎
    Renamed Amyris, Inc.
    Formerly Amyris Biotechnologies Inc.
  7. 🔔
    · approximate
    Initial public offering on Nasdaq as AMRS
  8. 2021
  9. 💰
    Record revenue of $342 million
    FY2021, the highest of the 5 years on record.

Events of Amyris Inc. from Wikidata, SEC EDGAR and the company's financial years. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

More about Amyris Inc.

Acquisitions and changes
No longer listed: it is not in the SEC's, Nasdaq Trader's and FINRA's lists of US-traded securities (checked 14 November 2026); its SEC filings show that it ended its SEC registration (Form 15) on 7 May 2024.

Market cap history

$0 M$382 M$765 M$1.1 B$1.5 B2023

World rank over time

▼ down 7,627 places since 2022
2022-01-07: #7650#7,65020222022-12-25: #10206#10,20620222023-07-30: #15277#15,2772023

Rank in USA: #2,165 (Jan 2022) · #2,288 (Dec 2022) · #3,090 (Jul 2023)

Key ratios

market cap and latest results · TTM = trailing 12 months
P/E ratio (TTM)
n/m (loss)
Price / sales (TTM)
—
Price / book
—
Free cash flow yield
—
Net margin (TTM)
-195.9%
Operating margin
-210.9%
Return on equity
—
Liabilities / assets
156.7%
Net debt
$829M
Revenue growth
-21.1%
R&D / revenue
40.8%
Revenue per employee
$275 K
Profit per employee
$-539 K

Financial history

USD · fiscal years · source: SEC filings
RevenueNet income
Fiscal year ending Dec 2015: revenue $34M, net income $-218M$34MFY15Fiscal year ending Dec 2016: revenue $67M, net income $-97M$67MFY16Fiscal year ending Dec 2017: revenue $128M, net income $-156M$128MFY17Fiscal year ending Dec 2018: revenue $64M, net income $-230M$64MFY18Fiscal year ending Dec 2019: revenue $153M, net income $-243M$153MFY19Fiscal year ending Dec 2020: revenue $173M, net income $-331M$173MFY20Fiscal year ending Dec 2021: revenue $342M, net income $-271M$342MFY21Fiscal year ending Dec 2022: revenue $270M, net income $-529M$270MFY22
Fiscal year endingRevenueGrowthOperating incomeNet incomeNet margin
Dec 2022$270M-21.1%$-569M$-529M-195.9%
Dec 2021$342M+97.4%$-178M$-271M-79.3%
Dec 2020$173M+13.5%$-123M$-331M-191.2%
Dec 2019$153M+139.9%$-122M$-243M-159.1%
Dec 2018$64M-50.2%$-137M$-230M-362.0%
Dec 2017$128M+90.0%$-56M$-156M-122.2%
Dec 2016$67M+96.7%$-96M$-97M-144.9%
Dec 2015$34M—$-149M$-218M-638.2%

Cash flow, debt and per share

Fiscal year endingOperating cash flowCapital spendingFree cash flowEPS (diluted)Dividend / share
Dec 2022$-526M——$-1.69—
Dec 2021$-181M——$-0.97—
Dec 2020$-176M——$-1.88—
Dec 2019$-157M——$-2.72—
Dec 2018$-109M——$-3.69—
Dec 2017$-101M——$-2.89—
Dec 2016$-82M——$-6.55—
Dec 2015$-85M——$-26.20—

SEC filings

  • May 7, 20248-KCurrent reportMaterial agreement · Agreement ended · New financial obligation · Unregistered share sale · Change in control · Directors or officers changed · Other events
  • Apr 23, 20248-KCurrent reportRegulation FD disclosure
  • Apr 8, 20248-KCurrent reportRegulation FD disclosure
  • Feb 28, 20248-KCurrent reportRegulation FD disclosure
  • Feb 9, 20248-KCurrent reportBankruptcy · Restructuring costs · Auditor change · Other events
  • Jan 4, 20248-KCurrent reportMaterial agreement
  • Dec 29, 20238-KCurrent reportMaterial agreement · Acquisition or disposal completed · Restructuring costs · Regulation FD disclosure
  • Dec 27, 20238-KCurrent reportDirectors or officers changed
  • Dec 13, 20238-KCurrent reportMaterial agreement · Regulation FD disclosure
  • Nov 29, 20238-KCurrent reportRegulation FD disclosure
  • Nov 22, 20238-KCurrent reportRegulation FD disclosure
  • Nov 7, 20238-KCurrent reportRegulation FD disclosure

Official filings of Amyris Inc. with the US Securities and Exchange Commission.

Annual results

Revenue
$270 M
Operating income
$-569 M
Net income
$-529 M

For year ending December-2022 · source: SEC filing

Balance sheet

Total assets
$825 M
Total liabilities
$1.3 B
Total equity
$-489 M

As of December-2022

Insider trading at Amyris Inc.#

Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.

Bought, 12 months
$0
0 purchases, 0 insiders
Sold, 12 months
$0
0 sales, 0 insiders
Net, 12 months
$0
open market only
Insiders on file
59
since
Amyris Inc.: latest insider trades
TradedInsiderTradeSharesPriceValueOwned afterFiling
filed Frank KungDirectorOtherindirect-6.80 M——0Form 4
filed Julie WashingtonDirectorOther-19,166——0Form 4
filed Hermanus KieftenbeldCFO AND INTERIM CEOOther-123,102——0Form 4
filed Steven Richard MillsDirectorOther-27,088——0Form 4
filed Ana DutraDirectorOther-10,950——0Form 4
filed Ryan PanchadsaramDirectorOther-35,785——0Form 4
filed Barbara HagerDirector, 10% ownerDisposal to the company-46,047——0Form 4
filed Lisa QiDirectorOther-37,471——0Form 4

Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals

Markets and events: Amyris Inc.#

Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.

Bankruptcy filing: (8-K); (8-K)

Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables

Amyris Inc. scorecard#

Passes 2 of the 14 checks that could be worked out: strongest in growth (2 of 6), weakest in profitability (0 of 4). Fiscal year 2022.

  • Valuationnot known
    • –P/E below its peers' medianNo market cap.
    • –Price to book below its peers' medianNo market cap.
    • –Price to sales below its peers' medianNo market cap.
    • –Free cash flow yield above 5%No market cap.
    • –Earnings yield above the 10-year Treasury yieldNo market cap.
    • –The price assumes slower growth than the last three years'No market cap.
  • Growth2 of 6
    • ✗Revenue grew in the newest year-21.1%Revenue down 21.1% in fiscal 2022.
    • ✓Revenue up more than 5% a year over three years20.9%20.9% a year over the three years to fiscal 2022.
    • ✓Faster growth over three years than its peers' median20.9%20.9% a year against Chemicals's median of -2.9% (60 companies).
    • ✗Earnings per share grew in the newest year-1.69 vs -0.97Diluted EPS -1.69 in fiscal 2022 against -0.97 the year before (report's currency).
    • ✗Net income higher than five years earlier-$529 M-$529 M in fiscal 2022 against -$156 M in 2017.
    • ✗Revenue rose in at least four of the last five years3 of 5Revenue rose in 3 of the five years to fiscal 2022.
  • Profitability0 of 4
    • ✗Profitable in the newest year-$529 MNet income -$529 M in fiscal 2022.
    • ✗Profitable in each of the last five years0 of 5Profitable in 0 of the five years to fiscal 2022.
    • ✗Operating margin above its peers' median-210.8%-210.8% against Chemicals's median of 4.4% (73 companies).
    • –Return on equity above 15%No return on equity (equity missing or negative).
    • –Return on invested capital above 10%No return on invested capital on file.
    • ✗Operating margin wider than three years earlier-210.8%-210.8% in fiscal 2022 against -79.9% in 2019.
  • Financial health0 of 3
    • ✗Short-term assets cover short-term liabilities0.8×Current ratio 0.79 at the end of fiscal 2022.
    • –Debt below equityDebt or equity is not on file (or equity is negative).
    • –Net debt below three years of EBITDANet debt to EBITDA is not on file.
    • ✗Operating income covers interest five times-23.0×Operating income -23.0 times interest in fiscal 2022.
    • ✗Cash from operations positive in each of the last three years0 of 3Positive in 0 of the three years to fiscal 2022.
    • –Altman Z-score outside the distress zoneThe Z-score's figures are not all on file.
  • Shareholder returns0 of 1
    • –Pays a dividendDividends are not on file.
    • –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
    • –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
    • ✗Share count up no more than 2% in a year15.9%Diluted shares up 15.9% in fiscal 2022.
    • –Dividends and buybacks above 3% of the market valueNo market cap.
    • –Free cash flow covers dividends and buybacksCash from operations or capital spending is not on file.

Worked out from the statements as filed (sec), the medians of Chemicals, the 10-year Treasury yield of Nov 13, 2026 and the market cap (too old for the valuation checks, which need one at most 60 days old). A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work

Amyris Inc.: financial statements#

Income statement, balance sheet and cash-flow statement as reported, newest period first.

Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).

Amyris Inc.: statements by fiscal year
PeriodTrendFY 2022to Dec 31, 2022FY 2021to Dec 31, 2021FY 2020to Dec 31, 2020FY 2019to Dec 31, 2019FY 2018to Dec 31, 2018FY 2017to Dec 31, 2017FY 2016to Dec 31, 2016FY 2015to Dec 31, 2015FY 2014to Dec 31, 2014FY 2013to Dec 31, 2013
Income statement
Revenue27034217315364128r67344341
Cost of revenue25915588763762r57373338
Research and development1109472716958r51455056
Selling, general and administrative4942581371279164r48565557
Total costs and expenses839519297274200184r163183143161
Operating income−569−178−123−122−137−56r−96−149−100−120
Interest and finance income——————0.30.30.40.2
Interest expense and finance costs252648594337r3879299.1
Share of profit of associates—−7.6−2.70———−4.2−2.9r0
Other non-operating income (expense)30−95−200−120−94−93r−0.9−65105r−116r
Income before tax−539−272r−324r−242−230−149r−97−213r5.6−236
Income tax−2.7−8.10.30.606.9r0.60.50.5−0.8
Net income including minority interests−543−272−327−243—−72−97−2182.2−235
Minority interests' share of net income−15−0.84.20———−0.1−0.10.2
Net income attributable to shareholders−529−271−331−243−230−156r−97−2182.3−235
Earnings per share, basic-1.65-0.93-1.88-2.67-3.69-2.89-6.12r-26.20r0.03-3.12
Earnings per share, diluted-1.69-0.97-1.88-2.72-3.69-2.89-6.55r-26.20r-0.90-3.12
Shares, weighted average (basic)321292204101603216r8.5r7875
Shares, weighted average (diluted)339293204101603218r8.5r12275
Balance sheet
Cash and cash equivalents6448330r0.345572712426.9
Short-term investments——————1.41.51.4—
Receivables—————24r14r4.08.77.7
Inventory1127543289.75.46.2111511
Other current assets5.43.21.42.6r1.9r1.2r1.74.6r6.59.5
Current assets3066391477492104r5934r7437
Property, plant and equipment18273332920145460119141
Right-of-use (leased) assets97321013——————
Goodwill14313100—0.60.60.60.60.6
Other intangible assets47390———00—9.1
Investments in associates3.09.42.44.70—————
Total assets825954223161128141r130106r216199
Accounts payable1908041512716r157.93.56.5
Debt due within a year1.90.95545124372636r176.4
Current liabilities387270163161212106r11076r4037
Long-term debt67530926484360r12973r10056
Lease liabilities (non-current)86209.715——————
Total liabilities1,293675390411340353r308265r341335
Retained earnings−2,880−2,358−2,087−1,756−1,521−1,290r−1,134−1,037−819−821
Shareholders' equity−489246−177−256−218−218r−184−158−124−135
Minority interests−13−0.84.80.60.90.90.9−0.4−0.6−0.6
Total equity−502246−172−255−217−217r−184−158−125−136
Total liabilities and equity825954223161128141r130106r216199
Shares outstanding365309245118774618r2067977
Cash-flow statement
Depreciation and amortization128.79.44.64.91111131517
Share-based compensation493314139.26.37.39.11418
Cash from operating activities−526−181−176−157−109−101r−82−85−85−106
Acquisitions, net of cash acquired−18−1800——————
Cash from investing activities−124−64−13−13−1252r5.6−5.1−9.8−10
Debt issued17667116189941964678311
Debt repaid−0.8−77−52−0.3r−42−38−9.8−41−5.7−3.3
Shares issued013100—5.80.20.62.51.1r
Cash from financing activities23170222312510878r926113191
Exchange-rate effect on cash0.50.4−4.3−0.3−0.10.2−0.3−1.2−1.21.3
Change in cash−41845730−45−1429r15−3035−24
Report10-K10-K10-K10-K10-K10-K/A10-K/A10-K/A10-K10-K

r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies

Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.

Source: SEC EDGAR filings (XBRL) · as of Mar 31, 2023. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative

Events at Amyris Inc.#

What the company reported to the SEC within four business days (Form 8-K), newest first.

Warning signs in the last three years

  • Bankruptcy or receivershipAuditor changedFiling

Bankruptcy or receivership 2 · Delisting notice 3 · Auditor changed 1 · Debt called early 1 · Restructuring 3 · Change in control 1 · Acquisition or sale completed 2 · Directors and officers 9 · Material agreement 17 · Agreement ended 1 · New debt 4 · Unregistered share sale 2 · Shareholder rights changed 2 · Shareholder vote 1 · Results announced 3

Amyris Inc.: events reported to the SEC
FiledWhat happenedFiling
Change in controlDirectors and officersMaterial agreementAgreement endedNew debtUnregistered share saleShareholder rights changed8-K
Bankruptcy or receivershipAuditor changedRestructuringShareholder rights changed8-K
Material agreement8-K
RestructuringAcquisition or sale completedMaterial agreement8-K
Directors and officers8-K
Material agreement8-K
Directors and officers8-K
Material agreement8-K
Material agreement8-K
Material agreement8-K
Material agreement8-K
Directors and officers8-K
Directors and officers8-K
Delisting notice8-K
Bankruptcy or receivershipDebt called earlyRestructuringDirectors and officersMaterial agreementNew debt8-K
Material agreement8-K
Directors and officers8-K
Material agreement8-K
Delisting noticeDirectors and officers8-K
Material agreement8-K
Delisting noticeShareholder vote8-K
Results announced8-K
Results announced8-K
Acquisition or sale completed8-K
Material agreement8-K
Results announced8-K
Material agreementNew debt8-K
Material agreement8-K
Material agreementUnregistered share sale8-K
Directors and officers8-K
Material agreementNew debt8-K

Source: SEC EDGAR, Form 8-K item numbers · as of May 7, 2024

Acquisitions and funding#

35 private funding rounds before listing

Private share sales · funding history

Private share sales of Amyris Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Sep 2022$8 MNo. 35$2 to $10 million1equity, optionsSEC
Jun 2020$200 MNo. 34$50 to $250 million53equitySEC
Jan 2020$94 MNo. 33$50 to $250 million7equity, optionsSEC
Jan 2020$10 MNo. 32$2 to $10 million4equity, optionsSEC
Nov 2019$4 MNo. 31$2 to $10 million1equity, optionsSEC
Nov 2019$8 MNo. 30$2 to $10 million2equity, optionsSEC
Oct 2019$8 MNo. 29$2 to $10 million1equity, optionsSEC
Oct 2019$6 MNo. 28$2 to $10 million1equity, optionsSEC
Sep 2019$13 MNo. 27$10 to $50 million3equity, optionsSEC
Aug 2019$19 MNo. 26$10 to $50 million1equity, optionsSEC
Aug 2019$10 MNo. 25$2 to $10 million2equity, optionsSEC
Apr 2019$75 MNo. 24$50 to $250 million9equity, optionsSEC
Apr 2019$36 MNo. 23$10 to $50 million1equity, optionsSEC
Dec 2018$60 MNo. 22$50 to $250 million2equity, debt, optionsSEC
Nov 2018$7 MNo. 21$2 to $10 million1equitySEC
Aug 2018$91 MNo. 20$50 to $250 million3equity, optionsSEC
Apr 2018$38 MNo. 19$10 to $50 million11equity, optionsSEC
Aug 2017$25 MNo. 18$10 to $50 million1equity, optionsSEC
May 2017$6 MNo. 17$2 to $10 million1equity, optionsSEC
May 2017$65 MNo. 16$50 to $250 million22equity, optionsSEC
Nov 2016$6 MNo. 15$2 to $10 million1equity, optionsSEC
Aug 2016$3 MNo. 14$2 to $10 million1equity, optionsSEC
May 2016$5 MNo. 13$2 to $10 million1equitySEC
Feb 2016$20 MNo. 12$10 to $50 million3debt, optionsSEC
Jul 2015$141 MNo. 11$50 to $250 million2equitySEC
Apr 2014$4 MNo. 10$2 to $10 million1equitySEC
Mar 2013$5 MNo. 9$2 to $10 million1equitySEC
Dec 2012$42 MNo. 8$10 to $50 million7equitySEC
May 2012$4 MNo. 7$2 to $10 million5equitySEC
Feb 2012$59 MNo. 6$50 to $250 million6equitySEC
Oct 2011$7 MIssued in a merger or acquisition$2 to $10 million1equitySEC
Sep 2010$14 MNo. 5$10 to $50 million3equitySEC
Jun 2010$133 MNo. 4$50 to $250 million1equitySEC
Mar 2010$48 MNo. 3$10 to $50 million1equitySEC
Jul 2009$61 MNo. 2$50 to $250 million34equitySEC
Feb 2008$2 MNo. 1$2 to $10 million3optionsSEC

Source: Annual reports and Form D notices filed with the SEC; Wikidata. Acquisitions are the businesses the company reports as acquired in its newest annual report, with the price paid. Funding rounds do not name their investors; the investors listed are those Wikidata records.

H-1B hiring at Amyris Inc.#

4 labor condition applications certified in fiscal 2026 for 4 positions, at a median wage of $141 K a year.

Certified, FY2026
4
#1,232 among companies on value.today
Worker positions
4
Median wage offered
$141 K
a year, full-time
Applications filed
4
Amyris Inc.: most frequent H-1B job titles in fiscal 2026
Job titlePositionsMedian wage offered
ScientistChemical Engineers2$150 K
Scientist 1Chemists1$131 K
Scientist 2, Analytical ChemistryChemists1$125 K

Where: Emeryville, CA 4

Amyris Inc.: labor condition applications by fiscal year
Fiscal yearCertifiedPositionsMedian wageFiled
FY202644$141 K4
FY202599$101 K10
FY20241010$105 K11
FY20231515$117 K16
FY20223131$119 K31
FY202188$96 K9
FY202077$119 K8

Source: US Department of Labor, LCA disclosure data. An application is not a visa: USCIS decides each petition later, and the yearly lottery limits new H-1B visas. Filed as Amyris, Inc.

Layoffs at Amyris Inc.#

From US state WARN notices and SEC 8-K restructuring filings, newest first.

People, last 12 months
0
0 notices and filings
People, all years
787
2023–2024
Latest
50 people
2024-10-01
Amyris Inc.: people laid off by year and month
YearJanFebMarAprMayJunJulAugSepOctNovDecTotal
2024·80·······50··130
2023·····65·260·112·220657
Amyris Inc.: latest layoffs
AnnouncedPeopleKindWhereSource
effective 50 peopleLayoffWARN noticeEmeryville, CaliforniaNotice list
80 peopleRestructuring planSEC 8-K“On February 7, 2024, the Company announced the termination or separation of approximately 80 employees, effective February 7, 2024.”Filing
220 peopleRestructuring planSEC 8-K“Item 2.05 Costs Associated With Exit or Disposal Activities In connection with the sale of certain consumer brands, the Company announced the termination or separation of approxima…”Filing
effective 89 peopleLayoffWARN noticeEmeryville, CaliforniaNotice list
effective 112 peopleLayoffWARN noticeEmeryville, CaliforniaNotice list
effective 62 peopleLayoffWARN noticeAlameda County, CaliforniaNotice list

Source: State WARN notices and SEC 8-K item 2.05

How Amyris Inc. compares in Chemicals

  • Revenue$270 M · higher than 17% of 421
  • Net margin-195.8% · higher than 1% of 409
  • Revenue growth-21.1% · higher than 13% of 111

Peer comparison · Chemicals

CompanyMarket capP/ENet marginRev. growth
Amyris Inc.🇺🇸$332 M—-195.8%-21.1%
Linde plc🇬🇧$231.0 B33.0×19.3%+3.0%
Air Liquide🇫🇷$124.8 B29.9×13.1%+3.8%
The Sherwin-Williams Company🇺🇸$81.4 B30.4×10.7%+2.1%
Ecolab Inc.🇺🇸$79.7 B38.3×12.0%+2.2%
Shin-Etsu Chemical Co., Ltd.🇯🇵$74.3 B23.1×18.4%—
Air Products and Chemicals, Inc.🇺🇸$66.5 B—-0.4%-0.5%
Nan Ya Plastics Corporation🇹🇼$55.1 B372.9×1.7%—
BASF SE🇩🇪$52.7 B27.4×2.7%-18.8%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Jul 30, 2023 (last known)
Annual results:
For year ending December-2022
Balance sheet:
As of December-2022
Employees:
As on 2021
Profile updated:
Nov 16, 2026

Figures from SEC filing, value.today research, Wikidata, Wikimedia Commons; financial statements from SEC filings.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Amyris Inc.? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Amyris Inc.'s ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Amyris Inc.? Suggest a correction